ArticleInternational journal of clinical oncology2022

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.

Hiroji Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.